With deep job cuts at the FDA, inspectors say the ongoing strain could compromise policing an industry spread across more than 90 countries.

“Things will be missed, we are going to have a lot less safe drugs,” a former inspector said.

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.

FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.

30

Replies

No replies yet